Application Nr Approved Date Route Status External Links
NDA021119 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Visudyne (Verteporfin For Injection) Therapy Is Indicated For The Treatment Of Patients With Predominantly Classic Subfoveal Choroidal Neovascularization (Cnv) Due To Age-Related Macular Degeneration (Amd), Pathologic Myopia Or Presumed Ocular Histoplasmosis. There Is Insufficient Evidence To Indicate Visudyne For The Treatment Of Predominantly Occult Subfoveal Cnv. Visudyne Therapy Is Indicated For The Treatment Of Patients With Predominantly Classic Subfoveal Choroidal Neovascularization Due To Age-Related Macular Degeneration, Pathologic Myopia Or Presumed Ocular Histoplasmosis. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Verteporfin VERTEPORFIN ZINC161410991

Comments